# Yi Lin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yi-lin-4/

## Facts

| Field | Value |
| --- | --- |
| Citations | 40,446 |
| Field | CAR-T cell therapy research |
| h-index | 80 |
| i10-index | 326 |
| Last Known Institution | Hohai University |
| OpenAlex ID | https://openalex.org/A5090694142 |
| ORCID iD | https://orcid.org/0000-0002-1556-6416 |
| Works | 997 |

## Researcher papers

- [Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma](https://scholariq.org/papers/idecabtagene-vicleucel-in-relapsed-and-refractory-multiple-myeloma/)
- [Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma](https://scholariq.org/papers/anti-bcma-car-t-cell-therapy-bb2121-in-relapsed-or-refractory-multiple-myeloma/)
- [Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study](https://scholariq.org/papers/ciltacabtagene-autoleucel-a-b-cell-maturation-antigen-directed-chimeric-antigen/)
- [Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma](https://scholariq.org/papers/prophylactic-corticosteroid-use-in-patients-receiving-axicabtagene-ciloleucel/)

## Researcher topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)

## Researcher university

- [Hohai University](https://scholariq.org/institutions/hohai-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.